Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study

European Radiology

Volumn 24, Issue 10, 2014, Pages 2467-2475

  Scheffer, H J ^a   Nielsen, K ^a   van Tilborg, A A J M ^a   Vieveen, J M ^a   Bouwman, R A ^a   Kazemier, G ^a   Niessen, H W M ^a   Meijer, S ^a   van Kuijk, C ^a   van den Tol, M P ^a   Meijerink, M R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ablation techniques adverse effects; Electroporation; Liver neoplasms surgery; Treatment outcome

Indexed keywords

ABLATION THERAPY; AGED; CANCER STAGING; COLORECTAL NEOPLASMS; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROPORATION; FEASIBILITY STUDY; FEMALE; HUMAN; LAPAROTOMY; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SECONDARY;

ABLATION TECHNIQUES; AGED; COLORECTAL NEOPLASMS; ELECTROPORATION; FEASIBILITY STUDIES; FEMALE; HEPATECTOMY; HUMANS; LAPAROTOMY; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930247597     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3259-x     Document Type: Article

References (34)

1. Ahmed M, Brace CL, Lee FT, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258:351–369
2. Abdalla EK, Vauthey J-N, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg Oncol 239:818–825, discussions 825–7
3. Nielsen K, van Tilborg AA, Meijerink MR et al (2013) Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 37:1340–1347
4. Wong SL, Mangu PB, Choti MA et al (2010) American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493–508
5. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation. Ann Surg 242:158–171
6. Wood TF, Rose DM, Chung M et al (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7:593–600
7. Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104
8. Phillips MA, Narayan R, Padath T, Rubinsky B (2012) Irreversible electroporation on the small intestine. Br J Cancer 106:490–495
9. Wendler JJ, Pech M, Porsch M et al (2012) Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Interv Radiol 35:921–926
10. Lee EW, Chen C, Prieto VE et al (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426–433
11. Charpentier KP, Wolf F, Noble L et al (2011) Irreversible electroporation of the liver and liver hilum in swine. HPB 13:168–173
12. Cannon R, Ellis S, Hayes D et al (2012) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107:544–549
13. Thomson K, Cheung W, Ellis S et al (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22:611–621
14. Martin RCG, McFarland K, Ellis S, Velanovich V (2012) Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 20:S443–S449
15. Kingham TP, Karkar AM, D’Angelica MI et al (2012) Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 215:379–387
16. Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 110:1305–1309
17. Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–S390
18. Fishbein MC, Meerbaum S, Rit J et al (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101:593–600
19. Muller-Eberhard HJ (1986) The membrane attack complex of complement. Ann Rev Immunol 4:503–528
20. Fishelson Z, Hochman I, Greene LE, Eisenberg E (2001) Contribution of heat shock proteins to cell protection from complement-mediated lysis. Int Immunol 13:983–991
21. Edd JF, Horowitz L, Davalos RV et al (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409–1415
22. Al-Sakere B, André F, Bernat C et al (2007) Tumor ablation with irreversible electroporation. PLoS One 2:e1135
23. Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6:287–294
24. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6:37–48
25. Guo Y, Zhang Y, Klein R et al (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70:1555–1563
26. Qin Z, Jiang J, Long G et al (2013) Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann Biomed Eng 41:619–629
27. Faroja M, Ahmed M, Appelbaum L et al (2012) Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266:462–470
28. Pech M, Janitzky A, Wendler JJ et al (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Interv Radiol 34:132–138
29. Appelbaum L, Ben-David E, Sosna J et al (2012) US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology 262:117–125
30. Davalos RV, Mir LM, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231
31. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM (2009) In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys Med Biol 54:5949–5963
32. Dunki-Jacobs EM, Philips P, Martin RC (2013) Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas. J Am Coll Surg 218:179–187
33. Arena CB, Sano MB, Rylander MN, Davalos RV (2011) Theoretical considerations of tissue electroporation with high-frequency bipolar pulses. IEEE Trans Biomed Eng 58:1474–1482
34. Appelbaum L, Ben-David E, Faroja M et al (2014) Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology 270:416–424